Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for ReposiTrak, Inc. (NYSE: TRAK), a Nevada corporation that operates a cloud-based food traceability, compliance and supply chain data platform. Through these filings, investors can review how the company reports its financial results, corporate actions and governance matters in accordance with SEC requirements.
ReposiTrak’s recent Form 8-K filings include disclosures about quarterly cash dividend declarations on its common stock, authorization of a 10b5-1 share repurchase program under a broader repurchase authorization, earnings releases for fiscal quarters and years, and the results of its annual meeting of stockholders. These current reports also reference attached press releases and earnings call transcripts that provide additional detail on financial performance, capital allocation and operational commentary.
In addition to current reports, ReposiTrak files periodic reports such as Form 10-K annual reports and Form 10-Q quarterly reports, which contain audited or reviewed financial statements, management’s discussion and analysis, risk factor disclosures and information on its business, including its focus on food traceability, regulatory compliance and supply chain solutions delivered through cloud-based applications.
Stock Titan’s filings page is designed to surface these documents as they are made available on EDGAR and to pair them with AI-powered summaries that explain the key points in accessible language. Users can quickly identify items such as dividend announcements, share repurchase authorizations, earnings results and shareholder meeting outcomes, and then drill into the underlying SEC reports for more detail. This same interface can also be used to monitor insider and executive transactions reported on forms such as Form 4, as those become available for ReposiTrak insiders.
ReposiTrak, Inc. director and chief executive officer Randall K. Fields reported indirect open-market sales of the company’s common stock by an affiliated charitable entity. On February 19, 2026, RK Fields Charitable 2022, LLC sold 4,500 shares at a weighted average price of $9.0652 per share. On February 20, 2026, the same entity sold 3,000 shares at a weighted average price of $8.8238 per share under a Rule 10b5-1 trading plan adopted to help meet charitable commitments. Following these transactions, this LLC held 107,500 shares, while Fields also reported 3,483,955 shares of common stock held directly and additional indirect holdings through other related entities and his spouse, as well as indirect holdings of Series B preferred stock.
ReposiTrak, Inc. reported solid results for its fiscal second quarter ended December 31, 2025, with revenue rising 7% to $5.9 million and operating income up 34% to $1.8 million, reflecting stronger profitability. GAAP net income to common shareholders increased 13% to $1.6 million, or $0.09 per basic and diluted share, compared with $0.08 a year earlier.
The company ended the quarter with $28.7 million in cash and no bank debt, while year-to-date operating cash flow reached $3.8 million. ReposiTrak continued returning capital by paying a quarterly dividend of $0.02 per share, repurchasing about 79,927 common shares for $1.1 million, and redeeming 70,093 preferred shares for roughly $750,000.
Management highlighted growing adoption of its ReposiTrak Traceability Network and new “Touchless Traceability” technology, supported by recent patent filings. They emphasized a largely recurring SaaS revenue base, rising margins, and a strategy focused on cross-selling, continued investment in traceability solutions, and steady capital returns to shareholders.
ReposiTrak, Inc. reported higher sales and profits for the quarter and six months ended December 31, 2025 while maintaining a strong cash position and returning capital to shareholders.
Quarterly revenue rose to $5.86 million from $5.49 million, driven mainly by recurring subscription and support services across compliance, supply chain and traceability. Net income applicable to common shareholders increased to $1.64 million, with diluted earnings per share of $0.09, up from $0.08 a year earlier, helped by lower cost of services and reduced depreciation and amortization.
For the first half of fiscal 2026, revenue reached $11.83 million and net income applicable to common shareholders was $3.40 million, both above the prior-year period. The company ended the quarter with $28.7 million in cash and cash equivalents and no bank debt, and generated $3.78 million in operating cash flow over six months.
ReposiTrak continued redeeming its Series B preferred stock and repurchased common shares under its long-running buyback program, while also paying cash dividends. A quarterly dividend of $0.02 per share was declared in December 2025. Management highlights growing demand for its traceability platform as the food industry prepares for U.S. FDA FSMA 204 traceability requirements, with the compliance deadline now extended to July 20, 2028.
ReposiTrak, Inc. insider trading disclosure: Randall K. Fields, the company’s Chief Executive Officer, director, and 10% owner, reported automatic sales of ReposiTrak common stock executed by RK Fields Charitable 2022, LLC under a prearranged Rule 10b5-1 trading plan.
The charitable LLC sold 3,000 shares on February 2, 2026 at a weighted average price of $10.4754 per share and 4,500 shares on February 4, 2026 at a weighted average price of $10.6195 per share. Following these transactions, the LLC held 119,500 and then 115,000 shares, respectively, while Fields also reported substantial additional direct and indirect beneficial ownership in common and Series B preferred stock.
ReposiTrak, Inc. insider activity shows stock sales by an entity affiliated with CEO, director and 10% owner Randall K. Fields. RK Fields Charitable 2022, LLC sold 2,500 common shares on February 2, 2026 at a weighted average price of $11.0061 and 5,000 shares on February 4, 2026 at a weighted average price of $10.4697. These automatic sales were made under a pre-arranged Rule 10b5-1 trading plan established to help meet charitable commitments. After these transactions, the LLC still held 122,500 shares, while Fields also reported direct ownership of 3,483,955 common shares and additional indirect holdings through Riverview Financial Corp., his spouse, Fields Management, Inc., and Series B preferred stock interests.
ReposiTrak, Inc. received an updated ownership disclosure from Handelsbanken Fonder, a Swedish mutual fund manager, on an amended Schedule 13G. As of December 31, 2025, Handelsbanken Fonder reported beneficial ownership of 1,177,900 shares of ReposiTrak common stock, representing 6.4% of the class.
The firm reports sole voting and dispositive power over all of these shares and no shared power with others. It certifies that the shares were acquired and are held in the ordinary course of business as a mutual fund complex, and not for the purpose of influencing control of ReposiTrak.
ReposiTrak, Inc.’s chief executive officer, director, and 10% owner Randall K. Fields reported an automatic sale of common stock by an affiliated charitable entity. On January 26, 2026, RK Fields Charitable 2022, LLC sold 7,500 shares of ReposiTrak common stock at a weighted average price of $11.0742 per share under a pre-arranged Rule 10b5-1 trading plan established to help meet charitable commitments. After this sale, RK Fields Charitable 2022, LLC held 130,000 common shares. Fields also reported 3,483,955 common shares held directly, and indirect common holdings including 615,260 shares through Riverview Financial Corp., 30,667 shares by his spouse, and 333,643 shares through Fields Management, Inc., plus Series B Preferred Stock held indirectly via Riverview Financial Corp. and his spouse.
ReposiTrak, Inc. insider holdings data show that RK Fields Charitable 2022, LLC, an entity associated with CEO, director and 10% owner Randall K. Fields, sold common stock in two Rule 10b5-1 plan transactions. The LLC sold 2,500 shares of common stock on January 20, 2026 at a weighted average price of $10.9697, and 5,000 shares on January 21, 2026 at a weighted average price of $10.9106. These sales were made under a pre-established Rule 10b5-1 trading plan adopted by Fields in his capacity as trustee of the 2022 RK Fields Charitable Remainder Unitrust to help meet charitable commitments, and the LLC now holds 137,500 common shares. Fields also reports additional ownership of ReposiTrak securities, including 3,483,955 common shares held directly, further common shares held through entities such as Riverview Financial Corp., his spouse and Fields Management, Inc., and Series B Preferred Stock held indirectly through Riverview Financial Corp. and his spouse.
ReposiTrak, Inc. insider filing shows planned charitable-related stock sales by entities associated with CEO and 10% owner Randall K. Fields. A Rule 10b5-1 trading plan for RK Fields Charitable 2022, LLC executed sales of ReposiTrak common stock on three days: 1,000 shares on 01/14/2026 at a weighted average price of $11.094, 3,600 shares on 01/15/2026 at $11.0786, and 2,900 shares on 01/16/2026 at $10.8452. The trading plan was established to help the reporting person meet charitable commitments.
After these transactions, RK Fields Charitable 2022, LLC held 145,000 shares of common stock. As of 01/14/2026, Randall K. Fields also beneficially owned 3,483,955 common shares directly, plus additional common and Series B preferred stock indirectly through Riverview Financial Corp., his spouse, Fields Management, Inc., and other related holdings.
ReposiTrak director Robert W. Allen reported selling 8,280 shares of Series B Preferred Stock at $10.70 per share on 12/31/2025. After this transaction, he directly held 22,411 shares of Series B Preferred Stock. He also reported direct ownership of 199,147 shares of common stock, plus indirect holdings of 587,476 common shares through a trust and 2,775 common shares held by his spouse.